Actinobacteria Metabolic Engineering

This group is located at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)

 

The growing resistance towards established antibiotics presents a serious problem especially with infectious diseases. The development of new drugs is mainly based on known molecules and mechanisms, which allows bacteria to assimilate rapidly. Hence, scientists are looking for novel drugs. At the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a branch of the Helmholtz Centre for Infection Research (HZI) at Braunschweig, the researchers develop new pathways, by which they force actinomycetes to produce hitherto unknown compounds.

Team

  • Dr Andriy Luzhetskyy

    Andriy Luzhetskyy

    Head of Junior Research Group Actinobacteria Metabolic Engineering

    +49 681 302-70215

    Contact

  • Natja Mellendorf

    Mellendorf Natja HIPS-MINS

    Secretary

    +49 681 302-70200

    Contact

  • Dr Liliya Horbal

    Liliya Horbal AMEG

    Post-Doc

    +49 681 302-70225

    Contact

  • Dr Maksym Myronovskyi

    Post-Doc

    +49 681 302-70220

    Contact

  • Suvd Nadmid

    Post-Doc

    +49 681 302-70225

    Contact

  • Dr Yuriy Rebets

    DSC 0019 Yuriy Rebets AMEG

    Post-Doc

    0681 302-70221

    Contact

  • Dr Bogdan Tokovenko

    Bogdan Tokovenko

    Post-Doc

    +49 681 302-70221

    Contact

  • Yousra Ahmed

    Yousra Ahmed

    PhD student

    +49 681 302-70222

    Contact

  • Oksana Bilyk

    Oksana Bilyk

    PhD student

    +49 681 302-70242

    Contact

  • Maria Lopatniuk

    Lopatniuk AMEG

    PhD student

    +49 681 302-70222

    Contact